Carregant...

Ganglionic Acetylcholine Receptor Autoantibody: Oncological, Neurological, and Serological Accompaniments

OBJECTIVE: To describe the clinical utility of the nicotinic ganglionic acetylcholine receptor (α3-AChR) autoantibody as a marker of neurological autoimmunity and cancer. DESIGN: Case-control study. SETTING: Mayo Clinic, Rochester, Minnesota. PATIENTS: A total of 15 000 patients seen at Mayo Clinic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: McKeon, Andrew, Lennon, Vanda A., Lachance, Daniel H., Fealey, Robert D., Pittock, Sean J.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3764484/
https://ncbi.nlm.nih.gov/pubmed/19506133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.2009.78
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!